The present invention relates to the compound of general formula (I): A-B-C (F, G')-D-E-F-G-A' or the compound of general formula (II): A-B-C (F ', G')-D-B-E-F-G-A' (II), wherein -A is at least one selected from perfluorocarbons (PFCs), perfluorinated silicon compounds and / or Molecules in the group of further perfluorinated compounds, -B is at least one predetermined breaking point in the form of a physically, chemically or enzymatically cleavable bond, -C is absent or is at least one linking molecule, -D is absent or is at least one spacer Molecule, -E is at least one member selected from the group consisting of nucleobases, nucleosides, nucleotides, oligonucleotides, nucleic acids, modified nucleobases, modified nucleosides, modified nucleotides, modified oligonucleotides , modified nucleic acids, peptide nucleic acid monomers, peptide nucleic acid oligomers and peptide nucleic acids or other nucleic acid analogues in the group of molecules, -F, F' is absent or is at least one ligand, -G, G' is absent Or be at least one marker molecule, -A' does not exist or is the meaning of A, and wherein compounds i), ii), iii), iv), v), vi) are excepted. The present invention also relates to the use of said compound for the non-viral transfer of molecule E into cells, the pharmaceutical composition containing said compound, and the use of said pharmaceutical composition.